(Q39940476)

English

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

scientific article published on 12 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145. (English)

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

0 references

1 reference

based on heuristic

cancer cell line

1 reference

based on heuristic

11

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

5

object named as

Burcak Karaca

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

7

object named as

Harika Atmaca

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

8

object named as

Selim Uzunoglu

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Bülent Karabulut

9

object named as

Bulent Karabulut

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

6

object named as

Gurbuz Gorumlu

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Ulus Ali Şanlı

10

object named as

Ulus A Sanli

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

4

object named as

Cigdem Erten

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Yuksel Kucukzeybek

1

object named as

Yuksel Kucukzeybek

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Ercument Cengiz

3

object named as

Ercument Cengiz

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

author name string

Mustafa K Gul

2

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

publication date

12 September 2008

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Journal of Experimental & Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

37

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1186/1756-9966-27-37

0 references

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Therapeutic options in androgen-independent prostate cancer: building on docetaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Survivin study: what is the next wave?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Overcoming multidrug resistance in taxane chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Vitamin A and apoptosis in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Chemistry and chemical biology of taxane anticancer agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Retinoids in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

22 September 2017

Retinoids in cancer chemoprevention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

25 September 2017

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

20 August 2018

Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

20 August 2018

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2553060

20 August 2018

Differential expression of nuclear retinoid receptors in normal and malignant prostates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18789152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18789152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18789152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18789152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoids as antitumor agents: a new age of biological therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18789152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-9966-27-37

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39940476&oldid=1967140056"